- Подготовка производственной площадки к маркировке
- Сроки внедрения маркировки для производителей: что нужно знать малым, средним и крупным?
- Оборудование для маркировки: какое нужно и что пригодится из того, что у вас уже есть?
- Состав кода маркировки молочной продукции
Release 4.66.0 MDLP February 1, 2025
Information about the content of the release in Russian can be found at this link
Installed on the Sandbox test environment: 29.01.2025
Installed on the production environment: 01.02.2025
XSD-schemes version: 1.38
Modifications
Added the “Export type” parameter into the general report on disposal
The “Export type” parameter was added into the “General report on disposal” report in a medicine circulation participant’s user account. The parameter can take one of the following values:
-
“—” (no value);
-
“Export to Uzbekistan”;
-
“Export to third countries”;
-
“Shipment of medicines in EAEU”.
Added the “Manufacturer indicated on the packaging of the medicine” parameter into a registry and card of the medicine
The “Manufacturer indicated on the packaging of the medicine” parameter (the column is hidden by default) was added into the “Medicines” → “Registry of medicines” in a medicine circulation participant’s user account. The new parameter was also added into a card of the medicine and is available in case of export of the registry.
To fill in or edit this field, go to the section “Medicines” → “Registry of medicines” → “Adjust”, then you will see a modal window — “Create request for medicine data correction”. The new parameter was added as well into the registry of requests for medicine data correction: “Medicines” → “Registry of requests for medicine data correction”.
Now the new field is optional. If you modify this field, it is necessary to attach a photo of the secondary package of the medicine for subsequent changes approval. Information about a manufacturer from this field will be displayed in a medicine card in Chestny ZNAK app.
New status transitions for schemes 552/23 and 391/1/16
The following status transitions were added for scheme 552 (“Registration in MDLP IS of information about medicinal drugs withdrawal from circulation for various reasons”) with a type of withdrawal from circulation 23 (“withdrawn from circulation in view of the write-off when there is no information according to BP”):
-
in_realization (“Shipped”) → out_of_circulation (“Withdrawn from circulation”);
-
transferred_to_agent (“Shipped under agent contract”) → out_of_circulation (“Withdrawn from circulation”);
-
change_owner_state_gov (“Awaiting confirmation of receipt by new owner”) → out_of_circulation (“Withdrawn from circulation”).
A possibility to write off expired SGTINs was added for all status transitions for 552/23.
The following status transitions were added for scheme 391 (“Registration in MDLP IS of information on re-introduction of medicine into circulation”) for medicines of good quality and with a reason of withdrawal from circulation 16 (“withdrawn from circulation in view of the write-off when there is no information according to BP”):
-
out_of_circulation (“Withdrawn from circulation”) → in_realization (“Shipped”);
-
out_of_circulation (“Withdrawn from circulation”) → transferred_to_agent (“Shipped under agent contract”);
-
out_of_circulation (“Withdrawn from circulation”) → change_owner_state_gov (“Awaiting confirmation of receipt by new owner”).
Expiration date checks were added for all status transitions for 391/1/16 after 552/23. Only unexpired medicines of good quality can be returned into circulation. Return of substandard medicines by using scheme 391 after scheme 552 is prohibited.
Updated list of the essential software needed for using a user account
Support of the deprecated browsers and operating systems has been discontinued. The following software requirements are established:
-
operating system:
-
Windows 10 or higher;
-
macOS 10 or higher.
-
browser:
-
“Safari” 14 or higher;
-
“Google Chrome” 90 or higher;
-
“Yandex Browser” 24 or higher.
Added “Controlled substances attribute” parameter into the registry of medicines and general registry of registered medicines
The “Controlled substances attribute” parameter was added in a medicine circulation participant’s user account into the following sections:
-
“Medicines” → “Registry of medicines”;
-
“Medicines” → “General registry of registered medicines”.
An attribute of controlled substances is available in case of export of the registry.
API modifications
Added the new field — “Export type” into the “General report on disposal” export
A new field — “Export type” was added into the “General report on disposal” analytical export (GENERAL_REPORT_ON_DISPOSAL). This field can take the following values:
-
“—” (no value);
-
“Export to Uzbekistan”;
-
“Export to third countries”;
-
“Shipment of medicines in EAEU”.
We remind you that you can obtain analytical exports by using the following API methods:
-
“Method of creation of new export task”;
-
“Method for obtaining a status of export task”;
-
“Method for getting the statuses of tasks for export”;
-
“Method for getting final data export identifiers”;
-
“Method of export obtainment”.
New output parameter — “Manufacturer indicated on the packaging of the medicine”
The “manufacturer” output parameter (“Manufacturer indicated on the packaging of the medicine”) was added into the following methods:
-
“Method for obtaining detailed information about a medicine manufactured by the company”;
-
“Method for obtaining public information about the manufactured medicine”;
-
“Method for obtaining information from the registry of medicines manufactured by the company”.
Filtering by an attribute of controlled substances is available
The “is_pku” (“Controlled substances” attribute) attribute contains a correct value and can be used for filtering in the following methods:
-
“Method for obtaining information from the registry of medicines manufactured by the company”;
-
“Method for obtaining detailed information about a medicine manufactured by the company”;
-
“Method for searching public information in the registry of the manufactured medicines”;
-
“Method for obtaining public information about the manufactured medicine”.